Candesic's Dr Leonid Shapiro has commented on the Bupa's M&A strategy in the HBI Intelligence.
Candesic is a leading strategy consultancy
head-quartered in London, serving private operators, investors, and public sector organisations.
Candesic proudly advised on Kester Capital investment
Candesic proudly advised on Kester Capital fifth investment in the life sciences sector into MAP Patient Access Limited, a specialist in market access consulting services to the pharmaceutical and biotech sectors. The mission of MAP Patient Access Limited is to make it easier for patients to access ground-breaking medicines, devices, and diagnostics. In addition to its expertise in rare and orphan diseases, it has a proven track record of helping its clients navigate increasingly complex healthcare reimbursement pathways.
HealthTechX Global 2023 was quite the event!
Thanks to all HealthTechX Global 2023- it was quite the event!
Candesic visits Imperial College Business School
This week our team visited Imperial College Business School. **Candesic** is a leading strategy consultancy providing CEO level clarity with R&D level insights for over 21 years.
© Candesic 2023